Japan start-up Innophys Co. is expanding overseas in nations that have aging populations to offer its wearable exoskeleton to support heavy lifting.
Set up by Tokyo University of Science professor Hiroshi Kobayashi, Innophys Co, hopes its products will be used in the care and farm fields in Europe, China, and South Korea, where similar age-related social issues occue.
Innophys Executive Officer Masaru Yoda said that with demand for assistive suits getting greater as populations age, they have a chance at being top in the world.
The firm has a domestic market share of about 70 percent. It sold around 20,000 Muscle Suit in April 2021 since launching it in 2014.
The exoskeletons support the arms and back.
They employ artificial muscles that are composed of rubber tubes covered in nylon mesh that expand when compressed air is added, creating a strong pulling force that can help with physically demanding manual activities and lessen back strain when lifting large goods.
The suit, which is worn like a backpack, can greatly reduce stress when performing heavy factory work, caregiving, and agricultural duties. It is also a useful tool for averting potential workplace mishaps.
Each item costs about 150,000 yen and weighs about 4 kg.
In 2020, Innophys began to expand into Taiwan, Hong Kong, and Macao. Currently, the company has sales representatives in 17 nations and areas, including China, South Korea, Germany, and France.


Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan
US Dollar Slips After PCE Inflation Data Eases Fed Rate Hike Expectations
Gold Prices Rise Above $4,000 as Inflation Data and Weaker Dollar Boost Demand
The four types of dementia most people don’t know exist
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Italy Investigates Microsoft Over Microsoft 365 AI Subscription Price Hike
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
South Korea’s KOSPI Plunges as Apple Price Hikes and OpenAI IPO Delay Shake AI Chip Stocks
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 



